B

Beam Therapeutics

Develops base editing–based precision medicines

mRNA Science Co-op

Translational Research & Bench BiologyConfirmed live in the last 24 hours
Internship · Winter 2027Cambridge, MA, USA$23 - $34 /hrIn-person

About the Job

Requirements

  • Pursuing a Bachelor of Science or Master of Science in Biological Sciences or a related field, such as Bioengineering, Biochemistry/Biophysics, or Cell Biology/Molecular Biology.
  • Have at least one year of relevant hands-on laboratory experience.
  • Have experience with mammalian cell culture and aseptic technique.
  • Have experience with mammalian cell transfection and cell-based assays.
  • Be proficient in Excel, PowerPoint, and data analysis.
  • Have experience maintaining a laboratory notebook and following written protocols.
  • Be currently enrolled in a degree-granting college or university program and maintain student status throughout the co-op.

Responsibilities

  • Maintain and culture mammalian cell lines for mRNA expression studies.
  • Perform transfection experiments to evaluate mRNA constructs with different sequence designs and chemical modifications.
  • Conduct protein expression and other biochemical assays to characterize mRNA performance.
  • Analyze and interpret experimental results using appropriate data analysis tools.
  • Process and evaluate multiple samples with careful attention to accuracy, consistency, and documentation.
  • Collaborate with other teams to support cell-based editing and mRNA evaluation studies.
  • Maintain detailed documentation of experiments in the ELN system.
  • Adhere to all laboratory safety requirements and procedures.
  • Contribute to molecular cloning, DNA preparation, and in vitro transcription (IVT) experiments as needed.

Desired Qualifications

  • Have experience with protein expression analysis or related biochemical assays.
  • Have experience with molecular cloning, plasmid DNA preparation, and in vitro transcription (IVT).
  • Be familiar with mRNA biology, gene expression studies, or nucleic acid therapeutics.

About the Company

Beam Therapeutics

Develops base editing–based precision medicines

Beam Therapeutics uses base editing to develop precision genetic medicines aimed at correcting disease-causing mutations. It focuses on R&D and collaborates with pharmaceutical companies and research institutions to fund and advance therapies, earning revenue through partnerships, licensing, upfront and milestone payments, and royalties. The company targets genetic disorders such as sickle cell disease with the goal of delivering lifelong cures, differentiating itself through its emphasis on durable genetic remedies and a science-driven, values-led culture.

Company size
501-1,000
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2017

Recently Posted Jobs

Explore more opportunities at Beam Therapeutics

See more jobs